Cancer-Fighting virus trial opens for patients out of options
Disease control
Recruiting now
This early-stage study tests a new drug called OTS-412, made from a modified virus, alone or with other drugs, in 27 adults with solid tumors that no longer respond to standard treatments. The main goal is to check safety and side effects, while also seeing if tumors shrink. It i…
Phase: PHASE1 • Sponsor: Bionoxx Inc. • Aim: Disease control
Last updated May 10, 2026 14:37 UTC